{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:24:33Z","timestamp":1792758273755,"version":"4.5.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background and objective<\/jats:title>\n                    <jats:p>The oncogenic effect of ionizing radiation is widely known. Sarcomas developing after radiation therapy (RT), termed \u201ciatrogenic disease of success\u201d, represent a growing problem, since the advancements in cancer management and screening programs have increased the number of long-term cancer survivors. Although many patients have been treated with radiation therapy, only few data are available on radiation-induced sarcomas (RIS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We examined the medical and radiological records of 186 patients with histologically proven soft tissue and bone sarcomas, which referred to IRCCS CROB Centro di Riferimento Oncologico della Basilicata from January 2009 to May 2022. Among them, seven patients received a histological diagnosis of secondary RIS, according to Cahan\u2019s criteria. Clinicopathological features and treatment follow-up data of RIS patients were retrospectively analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among these secondary RIS, five arose in irradiated breast cancer (5\/2,570, 0.19%) and two in irradiated head and neck cancer (2\/1,986, 0.10%) patients, with a mean onset latency time of 7.3 years.\n                      <jats:italic>\u00a0<\/jats:italic>\n                      The histology of RIS was one desmoid tumor, two angiosarcomas, one chondrosarcoma, two leiomyosarcomas, and one undifferentiated pleomorphic sarcoma.\u00a0Out of the seven RIS, one received radiotherapy, one received electrochemotherapy (ECT), one received a second-line chemotherapy, three were subjected to three lines of chemotherapy, and one underwent radiofrequency ablation, chemotherapy, and ECT. Median survival time is 36 months. No significant survival differences were found stratifying patients for age at RT, latency time, and age at RIS diagnosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>RIS represents a possible complication for long-survivor cancer patients. Therefore, adherence to a strict follow-up after the radiation treatment is recommended to allow early diagnosis and optimal management of RIS patients. After the planned follow-up period, considering the long-term risk to develop a RIS, a specific multispecialty survivorship care plan could be of benefit for patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2022.986123","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T02:47:22Z","timestamp":1664506042000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Radiation-induced sarcomas: A single referral cancer center experience and literature review"],"prefix":"10.3389","volume":"12","author":[{"given":"Simona","family":"Laurino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmila Carmen","family":"Omer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Albano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Bianculli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Pia","family":"Solazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sgambato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geppino","family":"Falco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabino","family":"Russi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Bochicchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.02.031","article-title":"RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort study","volume":"41","author":"Mirjolet","year":"2019","journal-title":"EBioMedicine"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.3635","article-title":"Cancer and radiation therapy: Current advances and future directions","volume":"9","author":"Baskar","year":"2012","journal-title":"Int J Med Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.soncn.2018.03.006","article-title":"The evolution of radiation therapy in treating cancer","volume":"34","author":"Abshire","year":"2018","journal-title":"Semin Oncol Nurs"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204927","article-title":"Post-radiation sarcoma: A study by the Eastern Asian musculoskeletal oncology group","volume":"13","author":"Joo","year":"2018","journal-title":"PLoS One"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2015-202963","article-title":"Sarcoma of the breast and chest wall after radiation treatment for bilateral breast carcinoma","volume":"68","author":"Pradniwat","year":"2015","journal-title":"J Clin Pathol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.radonc.2008.12.016","article-title":"Can we reduce the incidence of second primary malignancies occurring after radiotherapy? a critical review","volume":"91","author":"Tubiana","year":"2009","journal-title":"Radiother Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.10.5558","article-title":"Imaging of radiation-associated sarcoma","volume":"197","author":"O\u2019Regan","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1148\/81.6.992","article-title":"Bone sarcomas following radiation therapy","volume":"81","author":"Phillips","year":"1963","journal-title":"Radiology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(95)93157-3","article-title":"Sarcomas followig radiation therapy for breast cancer: A report of three cases and a review of the literature","volume":"31","author":"Pendlebury","year":"1995","journal-title":"Int J Radiat OncologyBiologyPhysics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/(sici)1097-0142(19980101)82:1<8::aid-cncr3>3.0.co;2-w","article-title":"Sarcoma arising in irradiated bone; report of 11 cases","volume":"1","author":"Cahan","year":"1948","journal-title":"Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-12-0810","article-title":"Patterns of bone sarcomas as a second malignancy in relation to radiotherapy in adulthood and histologic type","volume":"21","author":"Wu","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2020.101857","article-title":"Incidence of radiation induced sarcoma attributable to radiotherapy in adults: A retrospective cohort study in the SEER cancer registries across 17 primary tumor sites","volume":"70","author":"Snow","year":"2021","journal-title":"Cancer Epidemiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2011-0282","article-title":"Radiation-induced sarcoma of the breast: a systematic review","volume":"17","author":"Sheth","year":"2012","journal-title":"Oncologist"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.526360","article-title":"Radiation-induced sarcoma of the head and neck following radiotherapy for nasopharyngeal carcinoma: A single institutional experience and literature review","volume":"10","author":"Lou","year":"2020","journal-title":"Front Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-9473(02)00225-6","article-title":"On the exact distribution of maximally selected rank statistics","volume":"43","author":"Hothorn","year":"2003","journal-title":"Comput Stat Data Anal"},{"key":"B16","unstructured":"TherneauTM\n          A package for survival analysis in r2022"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1080\/02841860802047387","article-title":"Radiation-induced sarcoma: 25-year experience from the Norwegian radium hospital","volume":"47","author":"Bjerkehagen","year":"2008","journal-title":"Acta Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(91)90783-z","article-title":"Long-term risk of sarcoma following radiation treatment for breast cancer","volume":"21","author":"Taghian","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9776(98)90096-0","article-title":"Radiation-induced sarcomas following radiotherapy for breast cancer: Six case reports and a review of the literature","volume":"7","author":"Kirova","year":"1998","journal-title":"Breast"},{"key":"B20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13256-020-02482-x","article-title":"Tumors associated with radiotherapy: A case series","volume":"14","author":"Garcia","year":"2020","journal-title":"J Med Case Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2020.12.009","article-title":"Radiation-induced sarcoma: A retrospective population-based study over 34 years in a single institution","volume":"33","author":"Callesen","year":"2021","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.198","article-title":"Chemotherapy with radiotherapy influences time-to-development of radiation-induced sarcomas: A multicenter study","volume":"117","author":"Zhang","year":"2017","journal-title":"Br J Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000128686.51815.8b","article-title":"Long-term results with resection of radiation-induced soft tissue sarcomas","volume":"239","author":"Cha","year":"2004","journal-title":"Ann Surg"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3857\/roj.2021.00927","article-title":"Long-term oncological outcomes of hypofractionated versus conventional fractionated whole breast irradiation with simultaneous integrated boost in early-stage breast cancer","volume":"40","author":"Lertbutsayanukul","year":"2022","journal-title":"Radiat Oncol J"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.761393","article-title":"Hypofractionated radiotherapy in head and neck cancer elderly patients: A feasibility and safety systematic review for the clinician","volume":"11","author":"Piras","year":"2021","journal-title":"Front Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2055116919889159","DOI":"10.1177\/2055116919889159","article-title":"Radiation-induced sarcoma in a cat following hypofractionated, palliative intent radiation therapy for large-cell lymphoma","volume":"5","author":"Cook","year":"2019","journal-title":"JFMS Open Rep"},{"key":"B27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13014-016-0723-6","article-title":"Estimation of second cancer risk after radiotherapy for rectal cancer: comparison of 3D conformal radiotherapy and volumetric modulated arc therapy using different high dose fractionation schemes","volume":"11","author":"Zwahlen","year":"2016","journal-title":"Radiat Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00449","article-title":"Radiation-induced sarcoma of the head and neck: A review of the literature","volume":"8","author":"Giannini","year":"2018","journal-title":"Front Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.986123\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T02:47:24Z","timestamp":1664506044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.986123\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":28,"alternative-id":["10.3389\/fonc.2022.986123"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.986123","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]},"article-number":"986123"}}